Species identification after treatment for human taeniasis

Cesar Jeri; Robert H. Gilman; Andres G. Lescano; Holger Mayta; Maria E. Ramirez; Armando E. Gonzalez; Rahim Nazerali; Hector H. Garcia

doi:10.1016/S0140-6736(04)15791-7

Species identification after treatment for human taeniasis

Cesar Jeri, Robert H. Gilman, Andres G. Lescano, Holger Mayta, Maria E. Ramirez, Armando E. Gonzalez, Rahim Nazerali, Hector H. Garcia

Research output: Contribution to journal › Article › peer-review

59 Scopus citations

Abstract

Identification of species of human tapeworms is crucial because the consequences of infection by Taenia solium and T saginata are very different. However, evacuation of species-identifiable tapeworms is uncommon and Taenia spp eggs are indistinguishable under the microscope. Treatment of taeniasis consists of niclosamide followed by a purgative. Recently, we adopted preniclosamide and postniclosamide electrolyte-polyethyleneglycol salt (EPS) purges to improve bowel cleaning. Retrospective comparison of traditional castor oil with EPS purge showed that recovery of the tapeworm scolex was significantly improved (20 of 68 vs none of 46, p=0·0001) in the EPS group. Furthermore, 42 of 68 (62%) individuals receiving EPS excreted identifiable gravid proglottids. EPS treatment helps the visual identification of Taenia spp.

Original language	English
Pages (from-to)	949-950
Number of pages	2
Journal	The Lancet
Volume	363
Issue number	9413
DOIs	https://doi.org/10.1016/S0140-6736(04)15791-7
State	Published - 20 Mar 2004

Bibliographical note

Funding Information:
RHG, AGL, HM, AEG, and HHG are supported by research grants numbers P01 AI51976 and U01 AI35894 from the National Institute of Allergy and Infectious Diseases, NIH, USA, and grant number 063109 from the Wellcome Trust. The sponsors had no role in study design, data collection, data analysis, data interpretation, or writing of the report.

Access to Document

10.1016/S0140-6736(04)15791-7

Cite this

@article{af5774e6992d41a3b4262a7f4a7d91be,

title = "Species identification after treatment for human taeniasis",

abstract = "Identification of species of human tapeworms is crucial because the consequences of infection by Taenia solium and T saginata are very different. However, evacuation of species-identifiable tapeworms is uncommon and Taenia spp eggs are indistinguishable under the microscope. Treatment of taeniasis consists of niclosamide followed by a purgative. Recently, we adopted preniclosamide and postniclosamide electrolyte-polyethyleneglycol salt (EPS) purges to improve bowel cleaning. Retrospective comparison of traditional castor oil with EPS purge showed that recovery of the tapeworm scolex was significantly improved (20 of 68 vs none of 46, p=0·0001) in the EPS group. Furthermore, 42 of 68 (62%) individuals receiving EPS excreted identifiable gravid proglottids. EPS treatment helps the visual identification of Taenia spp.",

author = "Cesar Jeri and Gilman, {Robert H.} and Lescano, {Andres G.} and Holger Mayta and Ramirez, {Maria E.} and Gonzalez, {Armando E.} and Rahim Nazerali and Garcia, {Hector H.}",

note = "Funding Information: RHG, AGL, HM, AEG, and HHG are supported by research grants numbers P01 AI51976 and U01 AI35894 from the National Institute of Allergy and Infectious Diseases, NIH, USA, and grant number 063109 from the Wellcome Trust. The sponsors had no role in study design, data collection, data analysis, data interpretation, or writing of the report.",

year = "2004",

month = mar,

day = "20",

doi = "10.1016/S0140-6736(04)15791-7",

language = "Ingl{\'e}s",

volume = "363",

pages = "949--950",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Ltd.",

number = "9413",

}

TY - JOUR

T1 - Species identification after treatment for human taeniasis

AU - Jeri, Cesar

AU - Gilman, Robert H.

AU - Lescano, Andres G.

AU - Mayta, Holger

AU - Ramirez, Maria E.

AU - Gonzalez, Armando E.

AU - Nazerali, Rahim

AU - Garcia, Hector H.

N1 - Funding Information: RHG, AGL, HM, AEG, and HHG are supported by research grants numbers P01 AI51976 and U01 AI35894 from the National Institute of Allergy and Infectious Diseases, NIH, USA, and grant number 063109 from the Wellcome Trust. The sponsors had no role in study design, data collection, data analysis, data interpretation, or writing of the report.

PY - 2004/3/20

Y1 - 2004/3/20

N2 - Identification of species of human tapeworms is crucial because the consequences of infection by Taenia solium and T saginata are very different. However, evacuation of species-identifiable tapeworms is uncommon and Taenia spp eggs are indistinguishable under the microscope. Treatment of taeniasis consists of niclosamide followed by a purgative. Recently, we adopted preniclosamide and postniclosamide electrolyte-polyethyleneglycol salt (EPS) purges to improve bowel cleaning. Retrospective comparison of traditional castor oil with EPS purge showed that recovery of the tapeworm scolex was significantly improved (20 of 68 vs none of 46, p=0·0001) in the EPS group. Furthermore, 42 of 68 (62%) individuals receiving EPS excreted identifiable gravid proglottids. EPS treatment helps the visual identification of Taenia spp.

AB - Identification of species of human tapeworms is crucial because the consequences of infection by Taenia solium and T saginata are very different. However, evacuation of species-identifiable tapeworms is uncommon and Taenia spp eggs are indistinguishable under the microscope. Treatment of taeniasis consists of niclosamide followed by a purgative. Recently, we adopted preniclosamide and postniclosamide electrolyte-polyethyleneglycol salt (EPS) purges to improve bowel cleaning. Retrospective comparison of traditional castor oil with EPS purge showed that recovery of the tapeworm scolex was significantly improved (20 of 68 vs none of 46, p=0·0001) in the EPS group. Furthermore, 42 of 68 (62%) individuals receiving EPS excreted identifiable gravid proglottids. EPS treatment helps the visual identification of Taenia spp.

UR - http://www.scopus.com/inward/record.url?scp=1642291632&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(04)15791-7

DO - 10.1016/S0140-6736(04)15791-7

M3 - Artículo

C2 - 15043964

AN - SCOPUS:1642291632

SN - 0140-6736

VL - 363

SP - 949

EP - 950

JO - The Lancet

JF - The Lancet

IS - 9413

ER -

Species identification after treatment for human taeniasis

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this